INTERVIEW: Novartis' Oncology Chief On Sharpening Its Competitive Advantage

 
• By Jo Shorthouse

Novartis Oncology President Bruno Strigini talks about refining the pharma major's oncology strategy and its pipeline potential.

Cancer cell

More from Anticancer

More from Therapy Areas